FDA Inspection 1109126 — Supernus Pharmaceuticals, Inc.
The FDA completed an inspection of Supernus Pharmaceuticals, Inc. on Oct 10, 2019 in Rockville, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 10, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Rockville, MD (United States)